000			05095cam a2200733 i 4500
001			18031320
005			20230801143521.0
008			140205s2014 enka b 001 0 eng d
010			_a 2014932598
015			_aGBB441997 _2bnb
016	7		_a101640812 _2DNLM
016	7		_a016689368 _2Uk
020			_a9781783471096 _q(cloth)
020			_a1783471093 _q(cloth)
020			_z9781783471102 _q(e-ISBN)
035			_a(OCoLC)ocn890952019
040			_aYDXCP _beng _cYDXCP _erda _dNLGGC _dRCJ _dNLM _dUKMGB _dOCLCQ _dOCLCF _dCDX _dBTCTA _dCHVBK _dS1C _dCLU _dCOH _dKZF _dRID _dS3O _dDLC
042			_alccopycat
050	0	0	_aHD9665.5 _b.D835 2014
060	0	0	_a2014 J-829
060	1	0	_aQV 773
082	0	4	_a338.4/76151 _223
100	1		_aDukes, M. N. G. _q(Maurice Nelson Graham), _eauthor.
245	1	0	_aPharmaceuticals, corporate crime and public health / _cGraham Dukes, MD FRCP LLM, External Professor of Health Policy Studies, University of Oslo, Norway John Braithwaite, PhD, Professor, Regulatory Institutions Network, Australian national University, Canberra, Australia J.P. Moloney, MPhil, Health Policy Consultant, Melbourne, Australia.
264		1	_aCheltenham, UK ; _aNorthampton, MA : _bEdward Elgar Publishing, _c[2014]
264		4	_c©2014
300			_aix, 408 pages : _billustrations ; _c24 cm
336			_atext _btxt _2rdacontent
337			_aunmediated _bn _2rdamedia
338			_avolume _bnc _2rdacarrier
500			_aBook.
504			_aIncludes bibliographical references and index.
505	0	0	_tCreating a medicine : why, how and how not -- _tSafe, unsafe and improper manufacturing practices -- _tAggressive or misleading promotion -- _tThe dark art of manipulation : the industry and its puppets -- _tCorruption, counterfeiting and fraud -- _tPricing, monopolies, abuses and the law -- _tA criminological perspective on a worsening crisis -- _tPositive regulation : the complementary role of supports and sanctions -- _tA responsive criminal law of pharmaceuticals -- _tPrivatizing enforcement -- _tA new capitalism : a new drug diplomacy.
520			_a"Offering a considered analysis of pharmaceutical rights and wrongs as they have developed over the last half-century, this book is rich in new insights for managers in the pharmaceutical industry, regulatory agencies and health advocates." -- dust jacket
520	8		_a"The pharmaceutical industry must exist to serve the community, but over the years it has engaged repeatedly in corporate crime and anti-social behaviour, with the public footing the bill. This readable study by experts in medicine, law, criminology and public health, with deep experience of the industry, documents problems ranging from false advertising and counterfeiting to corruption, fraud and overpricing. It is a fresh and revealing look at the unacceptable pressures brought to bear on doctors, politicians, patients and the media. Uniquely, the book presents realistic and worldwide solutions for the future, with positive policies encouraging honest dealing, as well as partial privatization of enforcement and a transformation of science policy to develop the medicines that society needs most. The authors examine in turn each of the main facets of the pharmaceutical industry's activities--research, manufacturing, information, distribution and pricing--as well as some questionable aspects of its relationship with society. Offering a considered analysis of pharmaceutical rights and wrongs as they have developed, particularly over the last half-century, this book is rich in new insights for managers in the pharmaceutical industry, regulatory agencies and health agencies"--Publisher description.
650		0	_aPharmaceutical industry _xCorrupt practices.
650		0	_aCorporations _xCorrupt practices.
650		0	_aProduct counterfeiting.
650		0	_aDrugs _xStandards.
650	1	2	_aDrug Industry _xlegislation & jurisprudence
650	1	2	_aFraud
650	2	2	_aCrime
650	2	2	_aScientific Misconduct
650		7	_aCorporations _xCorrupt practices. _2fast _0(OCoLC)fst00879825
650		7	_aDrugs _xStandards. _2fast _0(OCoLC)fst00898923
650		7	_aPharmaceutical industry _xCorrupt practices. _2fast _0(OCoLC)fst01060133
650		7	_aProduct counterfeiting. _2fast _0(OCoLC)fst01078205
650		7	_aPharmazeutische Industrie. _2gnd _0(DE-588)4045696-1
650		7	_aKorruption. _2gnd _0(DE-588)4032524-6
650		7	_aArzneimittel. _2gnd _0(DE-588)4003115-9
650		7	_aProduktpiraterie. _2gnd _0(DE-588)4246534-5
650		7	_aWirtschaftskriminalität. _2gnd _0(DE-588)4066464-8
650	1	7	_aMisdrijven. _2gtt
650	1	7	_aFarmaceutische industrie. _2gtt _0(NL-LeOCL)078503787
650	1	7	_aGezondheidszorg. _2gtt
650		7	_aLäkemedelsindustrin _xetik och moral. _2sao
650		7	_aLäkemedelsindustrin _xekonomiska aspekter. _2sao
700	1		_aBraithwaite, John, _eauthor.
700	1		_aMoloney, J. P., _eauthor.
856			_yhttps://nhrc.gov.np/
906			_a7 _bcbc _ccopycat _d2 _encip _f20 _gy-gencatlg
942			_2NLM _cBK
999			_c3329 _d3329